Overall, dual MDM-2/TSPO inhibitors were effectiveagainst glioma cell lines and can be used as therapeutic agents againstcancer where p53 signaling is affected and TSPO is overexpressed. This evidence concerns the gene TP53 and central nervous system cancer.